Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
Drupal 8 - A Milestone in Flexibility, Performance and Enhanced Experience!
Drupal 8 is the World’s most used enterprise CMS. The best of Drupal was released on 19th of Nov'15. Valuebound was being an active part of the Drupal community
Drupal Global Training Day: Valuebound does it with fun!
Valuebound, in association with Bangalore Drupal User Group conducted a Free Drupal Training on 21st Nov 2015 on the occasion of Drupal Global Training Day. The Training was held as a part of…
My first experience and understanding of Drupal 8 theming
Theming in Drupal has undergone a lot of changes since Drupal 7, especially when talking about the twig template - a known template engine for PHP framework.
Drupal 8 Headless Hello World
I will be writing a series of article on Drupal-8 Headless. This article will focus on the simple headless hello world. We will first learn how to create a Hello World Module in Drupal-8. Oh! but…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
